◆BLACKSPECTER AI Chat öffnen →

BlackSpecter›Aktien›GILD

GILD (GILD)

Kennzahlen

Marktkapitalisierung

n/a

KGV (TTM)

n/a

Umsatz (TTM)

n/a

EBITDA

n/a

Dividendenrendite

n/a

52W Hoch

n/a

52W Tief

n/a

Beta

n/a

EPS (TTM)

n/a

Forward KGV

n/a

PEG Ratio

n/a

Short-Quote

n/a

Analysten-Ratings

Keine Analysten-Daten verfügbar

Earnings

Keine Earnings-Daten verfügbar

Aktuelle News

Zacks·vor 1 Tagen

Gilead Wins FDA Nod for Bixlenvo in Adults Living With HIV Infection

BioPharma Dive·vor 1 Tagen

Moderna raises $2.6B to support cancer work; FDA clears updated COVID vaccines

MT Newswires·vor 2 Tagen

Gilead Sciences Wins FDA Approval for HIV Pill Bixlenvo

Simply Wall St.·vor 2 Tagen

Gilead (GILD) Stock Looks Undervalued After A 147% Five Year Run

Business Wire·vor 2 Tagen

U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults With HIV, Including Those on Complex Regimens

Simply Wall St.·vor 2 Tagen

Gilead Sciences (GILD) Wins EU Trodelvy Approval, Is The Stock Fully Priced?

Frag BlackSpecter AI über GILD

Earnings-Analyse, Bewertungs-Check, Peer-Vergleich — in Sekunden.

Ist GILD kaufenswert?GILD Earnings Analyse GILD Bewertung

AI Chat öffnen →